CSafe Global has announced the FAA approval of the new CSafe RAP.

The CSafe RAP is the latest innovation in high performing temperature controlled containers (TCC) designed to support life-science companies with air cargo transportation of life-enhancing or life-saving products.

CSafe has recognized the increasing needs of pharmaceutical and life-science companies to ship large quantities of temperature-sensitive products to patients around the world.

The CSafe RAP utilizes innovative heating and compressor-driven cooling technologies together with advanced ThermoCor VIP insulation to eliminate the payload risks associated with extreme ambient temperature conditions and long-duration shipments. The new CSafe RAP active container system leverages the proven performance and capabilities of the well-established CSafe RKN to remove the operational and environmental challenges encountered with global temperature controlled shipments.

With its newly designed composite exterior panels, the CSafe RAP is not only durable, but is also voluminous, and can easily accommodate up to four standard US-pallets or five standard Euro-pallets. It is approved for use on both lower and upper decks of aircraft, thus allowing expansion of lanes and flights available to pharma companies for delivery of high-value biopharmaceutical products. The CSafe RAP provides an extended battery run time of more than 100 hours, a large payload volume of 6.68m3, and unmatched operational capabilities, maintaining constant payload temperatures even at extreme ambient temperatures from -30°C to +54°C.

“By upgrading to CSafe’s active RAP solution,” said Brian Kohr, President and CEO of CSafe Global, “shippers will benefit from the industry’s best performing temperature controlled container to transport their large shipments of valuable product effectively and successfully, time after time, with utmost confidence.”